Variants of the long control region of human papillomavirus type 16

被引:32
作者
Kurvinen, K
Yliskoski, M
Saarikoski, S
Syrjänen, K
Syrjänen, S
机构
[1] Univ Turku, Fac Med, Medicity Res Lab, FIN-20520 Turku, Finland
[2] Kuopio Univ Hosp, Dept Obstet & Gynecol, FIN-70211 Kuopio, Finland
[3] Univ Turku, Dept Oral Pathol & Oral Radiol, FIN-20520 Turku, Finland
基金
芬兰科学院; 英国医学研究理事会;
关键词
HPV; LCR; sequence variation; viral pathogenicity; cervical neoplasia;
D O I
10.1016/S0959-8049(00)00121-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of the human papillomavirus (HPV) E6 and E7 oncogenes is regulated on the transcriptional level by specific protein-binding sites contained in the viral long control region (LCR). Sequence changes within the LCR region may have an impact on the transcription of viral oncogenes, possibly resulting in differences in the oncogenic potential of the virus. The present study was designed to determine the sequence variability of the LCR of HPV 16 and to assess whether certain LCR variants do correlate with the clinical outcome of the disease of the uterine cervix. The entire LCR segment of HPV 16 was analysed from 37 cervical biopsy specimens derived from 28 women included in the Kuopio long-term prospective follow-up study. The LCR sequence was identical with the reference sequence in six HPV 16 isolates. Overall, 14 different HPV 16 LCR variants were identified. One of the variants showed sequence variation typical of the Asian-American variant lineage of HPV 16, and all the other variants appeared to belong to the European variant group. The European variants exhibited low genetic diversity, and only five of these LCR variants contained nucleotide changes involving known or proposed binding sites for transcription factors. The variants with changes at nucleotide positions 7193 and 7521 was the most prevalent, accounting for almost 37% of infections. This variant (7193; 7521) has been previously demonstrated to have similar transcriptional activity compared with the reference isolate by Veress and colleagues J Gen Virol 1999, 80, 1035-1043. The reference isolate, variant (7193; 7521) and variants with changes within transcription factor binding sites accounted for most of the infections, and no significant differences were found in the comparison of the distribution of these different LCR isolates in cases where the disease showed progression to severe cervical intraepithelial neoplasia (CIN) or carcinoma in situ (CIS). Notably, both the reference isolate and variant (7193; 7521) were also closely associated with infections showing more aggressive behaviour. According to the present findings, in European HPV 16 isolates, intratype genetic variation of the LCR region does not seem to be commonly responsible for differences in the pathogenicity of the virus and thereby for a risk of progressive infections. (C) 2000 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1402 / 1410
页数:9
相关论文
共 39 条
[1]  
Chen Z, 1997, CANCER RES, V57, P1614
[2]   THE ENHANCER OF HUMAN PAPILLOMAVIRUS TYPE-16 - BINDING-SITES FOR THE UBIQUITOUS TRANSCRIPTION FACTOR-OCT-1, FACTOR-NFA, FACTOR-TEF-2, FACTOR-NF1, AND FACTOR-AP-1 PARTICIPATE IN EPITHELIAL CELL-SPECIFIC TRANSCRIPTION [J].
CHONG, T ;
APT, D ;
GLOSS, B ;
ISA, M ;
BERNARD, HU .
JOURNAL OF VIROLOGY, 1991, 65 (11) :5933-5943
[3]   ANALYSIS OF THE PHYSICAL STATE OF DIFFERENT HUMAN PAPILLOMAVIRUS DNAS IN INTRAEPITHELIAL AND INVASIVE CERVICAL NEOPLASM [J].
CULLEN, AP ;
REID, R ;
CAMPION, M ;
LORINCZ, AT .
JOURNAL OF VIROLOGY, 1991, 65 (02) :606-612
[4]   ANALYSIS BY POLYMERASE CHAIN-REACTION OF THE PHYSICAL STATE OF HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN CERVICAL PRENEOPLASTIC AND NEOPLASTIC LESIONS [J].
DAS, BC ;
SHARMA, JK ;
GOPALAKRISHNA, V ;
LUTHRA, UK .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2327-2336
[5]   PREVALENCE OF DELETIONS OF YY1-BINDING SITES IN EPISOMAL HPV-16 DNA FROM CERVICAL CANCERS [J].
DONG, XP ;
STUBENRAUCH, F ;
BEYERFINKLER, E ;
PFISTER, H .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (06) :803-808
[6]   THE PHYSICAL STATE OF HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN BENIGN AND MALIGNANT GENITAL TUMORS [J].
DURST, M ;
KLEINHEINZ, A ;
HOTZ, M ;
GISSMANN, L .
JOURNAL OF GENERAL VIROLOGY, 1985, 66 (JUL) :1515-1522
[7]   THE E6/E7 PROMOTER OF HUMAN PAPILLOMAVIRUS TYPE-16 IS ACTIVATED IN THE ABSENCE OF E2 PROTEINS BY A SEQUENCE-ABERRANT SP1 DISTAL ELEMENT [J].
GLOSS, B ;
BERNARD, HU .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5577-5584
[8]   HUMAN PAPILLOMAVIRUSES IN THE PATHOGENESIS OF ANOGENITAL CANCER [J].
HAUSEN, HZ .
VIROLOGY, 1991, 184 (01) :9-13
[9]   THE GENETIC DRIFT OF HUMAN PAPILLOMAVIRUS TYPE-16 IS A MEANS OF RECONSTRUCTING PREHISTORIC VIRAL SPREAD AND THE MOVEMENT OF ANCIENT HUMAN-POPULATIONS [J].
HO, L ;
CHAN, SY ;
BURK, RD ;
DAS, BC ;
FUJINAGA, K ;
ICENOGLE, JP ;
KAHN, T ;
KIVIAT, N ;
LANCASTER, W ;
MAVROMARANAZOS, P ;
LABROPOULOU, V ;
MITRANIROSENBAUM, S ;
NORRILD, B ;
PILLAI, MR ;
STOERKER, J ;
SYRJAENEN, K ;
SYRJAENEN, S ;
TAY, SK ;
VILLA, LL ;
WHEELER, CM ;
WILLIAMSON, AL ;
BERNARD, HU .
JOURNAL OF VIROLOGY, 1993, 67 (11) :6413-6423
[10]   IMMORTALIZATION AND ALTERED DIFFERENTIATION OF HUMAN KERATINOCYTES INVITRO BY THE E6 AND E7 OPEN READING FRAMES OF HUMAN PAPILLOMAVIRUS TYPE-18 [J].
HUDSON, JB ;
BEDELL, MA ;
MCCANCE, DJ ;
LAIMINS, LA .
JOURNAL OF VIROLOGY, 1990, 64 (02) :519-526